Temat: "Hepatitis B Antibodies" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Higher disappearance rate of anti-HBs in Taiwanese freshers neonatally vaccinated with recombinant yeast hepatitis B vaccine.
Autorzy:: Hsu SH; The Department of Family Medicine, National Taiwan University Hospital, Taipei, Taiwan.
Chih AH; The School Health Center, National Taiwan University, Taipei, Taiwan.
Lee YC; The School Health Center, National Taiwan University, Taipei, Taiwan.
Huang KC; The Department of Family Medicine, National Taiwan University Hospital, Taipei, Taiwan.
Jan CF; The Department of Family Medicine, National Taiwan University Hospital, Taipei, Taiwan.; The School Health Center, National Taiwan University, Taipei, Taiwan.; Pokaż więcej
Źródło:: Liver international : official journal of the International Association for the Study of the Liver [Liver Int] 2017 Dec; Vol. 37 (12), pp. 1780-1787. Date of Electronic Publication: 2017 Apr 27.
Typ publikacji:: Comparative Study; Journal Article
MeSH Terms:: Hepatitis B Vaccines*
Hepatitis B Antibodies/*blood
Hepatitis B Antigens/*immunology
Adolescent ; Female ; Hepatitis B Antigens/blood ; Humans ; Infant ; Infant, Newborn ; Male ; Retrospective Studies ; Vaccination/statistics & numerical data ; Vaccines, Synthetic ; Young Adult

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Interpreting hepatitis B serologies.
Autorzy:: Alter MJ
Moyer LA; Pokaż więcej
Źródło:: Seminars in dialysis [Semin Dial] 2001 Sep-Oct; Vol. 14 (5), pp. 402-3.
Typ publikacji:: Journal Article
MeSH Terms:: Hepatitis B Antibodies*
Hepatitis B Antigens*
Renal Dialysis*
Hepatitis B/*diagnosis
Hepatitis B/immunology ; Humans

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: Reestablishment of active immunity against HBV graft reinfection after liver transplantation for HBV-related end stage liver disease.
Autorzy:: Lu SC; Department of Hepatobiliary Surgery and Liver Transplantation Program, Beijing You-An Hospital, Capital Medical University, Beijing 100069, China ; Institute & Hospital of Hepatobiliary Surgery, Key Laboratory of Digital Hepatobiliary Surgery of Chinese PLA, Chinese PLA Medical School, Chinese PLA General Hospital, 28 Fuxing Road, Beijing 100853, China.
Jiang T; Department of Hepatobiliary Surgery and Liver Transplantation Program, Beijing You-An Hospital, Capital Medical University, Beijing 100069, China.
Lai W; Department of General Surgery, Chengdu First People's Hospital, Sichuan 610041, China.
Liu Y; Department of Hepatobiliary Surgery and Liver Transplantation Program, Beijing You-An Hospital, Capital Medical University, Beijing 100069, China.
Zhang J; Department of Hepatobiliary Surgery and Liver Transplantation Program, Beijing You-An Hospital, Capital Medical University, Beijing 100069, China.
Zeng DB; Department of Hepatobiliary Surgery and Liver Transplantation Program, Beijing You-An Hospital, Capital Medical University, Beijing 100069, China.
Li CY; Department of Hepatobiliary Surgery and Liver Transplantation Program, Beijing You-An Hospital, Capital Medical University, Beijing 100069, China.
Wang ML; Department of Hepatobiliary Surgery and Liver Transplantation Program, Beijing You-An Hospital, Capital Medical University, Beijing 100069, China.
Lin DD; Department of Hepatobiliary Surgery and Liver Transplantation Program, Beijing You-An Hospital, Capital Medical University, Beijing 100069, China.
Zhu Y; Department of Hepatobiliary Surgery and Liver Transplantation Program, Beijing You-An Hospital, Capital Medical University, Beijing 100069, China.
Li YP; Key Laboratory of Transplant Engineering and Immunology of Health Ministry, West China Hospital, Sichuan University, Chengdu, Sichuan 610044, China.
Li N; Department of Hepatobiliary Surgery and Liver Transplantation Program, Beijing You-An Hospital, Capital Medical University, Beijing 100069, China.; Pokaż więcej
Źródło:: Journal of immunology research [J Immunol Res] 2014; Vol. 2014, pp. 764234. Date of Electronic Publication: 2014 Dec 17.
Typ publikacji:: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Hepatitis B Vaccines*
Liver Transplantation*
Antiviral Agents/*administration & dosage
End Stage Liver Disease/*immunology
Hepatitis B/*immunology
Hepatitis B Antigens/*administration & dosage
Hepatitis B virus/*immunology
Adult ; Aged ; End Stage Liver Disease/complications ; End Stage Liver Disease/therapy ; Feasibility Studies ; Female ; Follow-Up Studies ; Graft Survival ; Hepatitis B/complications ; Hepatitis B/therapy ; Hepatitis B Antibodies/blood ; Humans ; Immunity/drug effects ; Male ; Middle Aged ; Prospective Studies ; Transplants/immunology ; Transplants/virology ; Virus Activation/drug effects